Cathay Global Genomics Immunology And Medical Revolution ETF (TPE:00898)

Assets	1.24B
Expense Ratio	1.05%
PE Ratio	18.34
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	+70.88%

Volume	875,841
Open	11.47
Previous Close	11.45
Day's Range	11.47 - 11.53
52-Week Low	6.54
52-Week High	11.53
Beta	0.28
Holdings	n/a
Inception Date	Nov 22, 2021

About 00898

00898.TW was created on 2021-11-22 by Cathay. The fund's investment portfolio concentrates primarily on health care equity.

• Asset Class: Equity
• Category: Health Care
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 00898
• Provider: Cathay
• Index Tracked: Solactive Global Genomics Immunology and Medical Revolution Index - Benchmark TR Net

Performance

00898 had a total return of 70.88% in the past year, including dividends. Since the fund's inception, the average annual return has been 3.11%.

Data Sources: S&P Global Market Intelligence and Finnhub

Historical data is provided by S&P Global Market Intelligence. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error